Editorial: Cancer treatment-related cardiovascular disease - real world data in cardio-oncology.
作者信息
Agarwala Vivek, Ghosh Arjun, Guha Avirup, Parikh Purvish M, Dent Susan
机构信息
Medical Oncology & Hemat-Oncology, Narayana Superspeciality Hospital & Cancer Institute, Howrah and RN Tagore International Institute of Cardiac Sciences (RTIICS), Kolkata, India.
Cardiology, Barts Heart Centre and University College London Hospital, London, United Kingdom.
出版信息
Front Oncol. 2023 Sep 20;13:1277042. doi: 10.3389/fonc.2023.1277042. eCollection 2023.
Abstract
摘要
相似文献
1
Editorial: Cancer treatment-related cardiovascular disease - real world data in cardio-oncology.社论：癌症治疗相关心血管疾病——心脏肿瘤学中的真实世界数据
Front Oncol. 2023 Sep 20;13:1277042. doi: 10.3389/fonc.2023.1277042. eCollection 2023.
2
Long-term and real-life incidence of cancer therapy-related cardiovascular toxicity in patients with breast cancer: a Swedish cohort study.乳腺癌患者癌症治疗相关心血管毒性的长期及实际发生率：一项瑞典队列研究
Front Oncol. 2023 Apr 19;13:1095251. doi: 10.3389/fonc.2023.1095251. eCollection 2023.
3
Global longitudinal strain at 3 months after therapy can predict late cardiotoxicity in breast cancer.治疗后 3 个月的整体纵向应变可预测乳腺癌的迟发性心脏毒性。
Cancer Med. 2023 Jun;12(12):13374-13387. doi: 10.1002/cam4.6039. Epub 2023 May 15.
4
Cardiovascular toxicity of checkpoint inhibitors: review of associated toxicity and design of the Spanish Immunotherapy Registry of Cardiovascular Toxicity.检查点抑制剂的心血管毒性：相关毒性的综述及西班牙免疫治疗心血管毒性注册研究的设计。
Clin Transl Oncol. 2023 Nov;25(11):3073-3085. doi: 10.1007/s12094-023-03217-2. Epub 2023 May 25.
5
Advanced Echocardiographic Techniques in Cardio-Oncology: the Role for Early Detection of Cardiotoxicity.心血管肿瘤学中的高级超声心动图技术：早期检测心脏毒性的作用。
Curr Cardiol Rep. 2022 Sep;24(9):1109-1116. doi: 10.1007/s11886-022-01728-y. Epub 2022 Jul 26.
6
Investigating the efficacy of osimertinib and crizotinib in phase 3 clinical trials on anti-cancer treatment-induced cardiotoxicity: are real-world studies the way forward?探讨奥希替尼和克唑替尼在 3 期临床试验中治疗抗肿瘤治疗相关心脏毒性的疗效：真实世界研究是未来的方向吗？
J Oncol Pharm Pract. 2023 Apr;29(3):646-662. doi: 10.1177/10781552221077417. Epub 2022 Feb 15.
7
Modeling Precision Cardio-Oncology: Using Human-Induced Pluripotent Stem Cells for Risk Stratification and Prevention.精准心脏肿瘤学建模：利用人诱导多能干细胞进行风险分层和预防。
Curr Oncol Rep. 2021 May 3;23(7):77. doi: 10.1007/s11912-021-01066-2.
8
Cardiovascular Complications of Pan-Cancer Therapies: The Need for Cardio-Oncology.泛癌疗法的心血管并发症：心脏肿瘤学的必要性。
Cancers (Basel). 2023 Jun 5;15(11):3055. doi: 10.3390/cancers15113055.
9
Cardiotoxicity Induced by Immune Checkpoint Inhibitors: What a Cardio-Oncology Team Should Know and Do.免疫检查点抑制剂所致心脏毒性：心脏肿瘤团队应了解与应对的事项
Cancers (Basel). 2022 Nov 2;14(21):5403. doi: 10.3390/cancers14215403.
10
QTc prolongation risk among patients receiving oral targeted antineoplastic medications: A real-world community-based oncology analysis.接受口服靶向抗肿瘤药物治疗的患者的QTc延长风险：一项基于社区肿瘤学的真实世界分析。
Front Oncol. 2023 Mar 10;13:1098333. doi: 10.3389/fonc.2023.1098333. eCollection 2023.
本文引用的文献
1
Global Cardio Oncology Registry (G-COR): Registry Design, Primary Objectives, and Future Perspectives of a Multicenter Global Initiative.全球心血管肿瘤注册研究（G-COR）：一项多中心全球倡议的注册设计、主要目标和未来展望。
Circ Cardiovasc Qual Outcomes. 2023 Oct;16(10):e009905. doi: 10.1161/CIRCOUTCOMES.123.009905. Epub 2023 Sep 13.
2
Advancing Cardio-Oncology in Asia.推动亚洲心血管肿瘤学发展。
Korean Circ J. 2023 Feb;53(2):69-91. doi: 10.4070/kcj.2022.0255.
3
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS).2022年欧洲心脏病学会（ESC）与欧洲血液学协会（EHA）、欧洲治疗放射学与肿瘤学协会（ESTRO）以及国际心脏肿瘤学会（IC-OS）合作制定的心脏肿瘤学指南。
Eur Heart J. 2022 Nov 1;43(41):4229-4361. doi: 10.1093/eurheartj/ehac244.
4
Association Between Up-front Surgery and Risk of Stroke in US Veterans With Oropharyngeal Carcinoma.美国口咽癌退伍军人中 upfront 手术与中风风险的相关性。
JAMA Otolaryngol Head Neck Surg. 2022 Aug 1;148(8):740-747. doi: 10.1001/jamaoto.2022.1327.
5
QT Prolongation in Cancer Patients.癌症患者的QT间期延长
Front Cardiovasc Med. 2021 Feb 25;8:613625. doi: 10.3389/fcvm.2021.613625. eCollection 2021.
6
The incidence of myocardial infarction and stroke in head and neck cancer patients.头颈部癌症患者的心肌梗死和中风发病率。
Sci Rep. 2021 Feb 18;11(1):4174. doi: 10.1038/s41598-021-83665-4.
7
Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.多发性骨髓瘤：欧洲血液学协会-欧洲肿瘤内科学会诊断、治疗及随访临床实践指南
Ann Oncol. 2021 Mar;32(3):309-322. doi: 10.1016/j.annonc.2020.11.014. Epub 2021 Feb 3.
8
From trends to transformation: where cardio-oncology is to make a difference.从趋势到变革：心脏肿瘤学的用武之地。
Eur Heart J. 2019 Dec 21;40(48):3898-3900. doi: 10.1093/eurheartj/ehz781.
9
National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Cardiovascular Disease and Associated Risk Factors Working Group Report.美国国立卫生研究院造血细胞移植迟发效应倡议：心血管疾病及相关危险因素工作组报告。
Biol Blood Marrow Transplant. 2017 Feb;23(2):201-210. doi: 10.1016/j.bbmt.2016.08.019. Epub 2016 Aug 30.
10
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC).2016年欧洲心脏病学会（ESC）实践指南委员会主持制定的关于癌症治疗与心血管毒性的立场文件：欧洲心脏病学会（ESC）癌症治疗与心血管毒性特别工作组。
Eur Heart J. 2016 Sep 21;37(36):2768-2801. doi: 10.1093/eurheartj/ehw211. Epub 2016 Aug 26.
Zotero 插件